Pain Control Following Breast Augmentation: A Qualitative Systematic Review

American Society for Aesthetic Plastic Surgery 2011 National Cosmetic Surgery Data Bank Statistics. http://www.surgery.org/sites/default/files/2011-quickfacts.pdf. Accessed July 13, 2012.

Kryger, 2008, Decreased postoperative pain, narcotic, and antiemetic use after breast reduction using a local anesthetic pain pump, Ann Plast Surg, 61, 147, 10.1097/SAP.0b013e31815a23ef

Rawlani, 2008, A local anesthetic pump reduces postoperative pain and narcotic and antiemetic use in breast reconstruction surgery: a randomized controlled trial, Plast Reconstr Surg, 122, 39, 10.1097/PRS.0b013e3181774349

Rohde, 2010, Effects of pulsed electromagnetic fields on interleukin-1 beta and postoperative pain: a double-blind, placebo-controlled, pilot study in breast reduction patients, Plast Reconstr Surg, 125, 1620, 10.1097/PRS.0b013e3181c9f6d3

Larson, 2010, The effect of electroacustimulation on postoperative nausea, vomiting, and pain in outpatient plastic surgery patients: a prospective, randomized, blinded, clinical trial, Plast Reconstr Surg, 125, 989, 10.1097/PRS.0b013e3181ccdc23

Romundstad, 2006, Chronic pain and sensory changes after augmentation mammoplasty: long term effects of preincisional administration of methylprednisolone, Pain, 124, 92, 10.1016/j.pain.2006.03.020

Tebbetts, 2002, Achieving a predictable 24-hour return to normal activities after breast augmentation, part I: refining practices by using motion and time study principles, Plast Reconstr Surg, 109, 273, 10.1097/00006534-200201000-00044

Tebbetts, 2002, Achieving a predictable 24-hour return to normal activities after breast augmentation, part II: patient preparation, refined surgical techniques, and instrumentation, Plast Reconstr Surg, 109, 293, 10.1097/00006534-200201000-00046

Wu, 2005, Efficacy of continuous local anesthetic infusion for postoperative pain after radical retropubic prostatectomy, Urology, 66, 366, 10.1016/j.urology.2005.02.030

Liu, 2006, Efficacy of continuous wound catheters delivering local anesthetic for postoperative analgesia: a quantitative and qualitative systematic review of randomized controlled trials, J Am Coll Surg, 203, 914, 10.1016/j.jamcollsurg.2006.08.007

Baroody, 2004, Efficacy of the pain pump catheter in immediate autologous breast reconstruction, Plast Reconstr Surg, 114, 895, 10.1097/01.PRS.0000133173.71201.3C

Boehmler, 2009, Decreased narcotic use with an implantable local anesthetic catheter after deep inferior epigastric perforator flap breast reconstruction, Ann Plast Surg, 62, 618, 10.1097/SAP.0b013e31817fe61c

Culliford, 2007, Intraoperative Sensorcaine significantly improves postoperative pain management in outpatient reduction mammaplasty, Plast Reconstr Surg, 120, 840, 10.1097/01.prs.0000277647.42662.29

Di, 2001, Role of pre-emptive analgesia in reduction mammaplasty, Scand J Plast Reconstr Surg Hand Surg, 35, 297, 10.1080/028443101750523212

Heller, 2008, Prospective, randomized, double-blind trial of local anesthetic infusion and intravenous narcotic patient-controlled anesthesia pump for pain management after free TRAM flap breast reconstruction, Plast Reconstr Surg, 122, 1010, 10.1097/PRS.0b013e3181858c09

Layeeque, 2004, Botulinum toxin infiltration for pain control after mastectomy and expander reconstruction, Ann Surg, 240, 608, 10.1097/01.sla.0000141156.56314.1f

Freedman, 2008, Pregabalin has opioid-sparing effects following augmentation mammaplasty, Aesthetic Surg J, 28, 421, 10.1016/j.asj.2008.04.004

Jabs, 2008, Quantitative effects of tumescent infiltration and bupivicaine injection in decreasing postoperative pain in submuscular breast augmentation, Aesthetic Surg J, 28, 528, 10.1016/j.asj.2008.07.005

Legeby, 2009, Placebo-controlled trial of local anaesthesia for treatment of pain after breast reconstruction, Scand J Plast Reconstr Surg Hand Surg, 43, 315, 10.1080/02844310903259108

Mahabir, 2008, Locally administered ketorolac and bupivacaine for control of postoperative pain in breast augmentation patients, part II: 10-day follow-up, Plast Reconstr Surg, 121, 638, 10.1097/01.prs.0000298112.52389.e1

Pacik, 2010, Pain control in augmentation mammaplasty: the use of indwelling catheters in 813 consecutive patients, Plast Reconstr Surg, 125, 1814, 10.1097/PRS.0b013e3181d0aa26

Parsa, 2009, Combined preoperative use of celecoxib and gabapentin in the management of postoperative pain, Aesthetic Plast Surg, 33, 98, 10.1007/s00266-008-9230-y

Rawal, 2006, Pain relief following breast augmentation surgery: a comparison between incisional patient-controlled regional analgesia and traditional oral analgesia, Eur J Anaesthesiol, 23, 1010, 10.1017/S0265021506000883

Zhibo, 2009, Effect of sustained-release lidocaine on reduction of pain after subpectoral breast augmentation, Aesthetic Surg J, 29, 32, 10.1016/j.asj.2008.10.008

Freedman, 2008, Pregabalin has opioid-sparing effects following augmentation mammaplasty, Aesthetic Surg J, 28, 421, 10.1016/j.asj.2008.04.004

Heden, 2008, Effects of pulsed electromagnetic fields on postoperative pain: a double-blind randomized pilot study in breast augmentation patients, Aesthetic Plast Surg, 32, 660, 10.1007/s00266-008-9169-z

Kazmier, 2008, A prospective, randomized, double-blind, controlled trial of continuous local anesthetic infusion in cosmetic breast augmentation, Plast Reconstr Surg, 121, 711, 10.1097/01.prs.0000299372.91051.1b

Mahabir, 2004, Locally administered ketorolac and bupivacaine for control of postoperative pain in breast augmentation patients, Plast Reconstr Surg, 114, 1910, 10.1097/01.PRS.0000142996.50331.2C

McCarthy, 2009, Efficacy of pocket irrigation with bupivacaine and ketorolac in breast augmentation: a randomized controlled trial, Ann Plast Surg, 62, 15, 10.1097/SAP.0b013e31817e9c5b

Parsa, 2005, The use of celecoxib for reduction of pain after subpectoral breast augmentation, Aesthetic Plast Surg, 29, 441, 10.1007/s00266-005-0032-1

Zhibo, 2009, Botulinum toxin type A infiltration for pain control after breast augmentation, Plast Reconstr Surg, 124, 263e, 10.1097/PRS.0b013e3181b98c34

Cooter, 2007, Day case breast augmentation under paravertebral blockade: a prospective study of 100 consecutive patients, Aesthetic Plast Surg, 31, 666, 10.1007/s00266-006-0230-5

Toradol, 2008

Chin, 2011, Ketorolac in thyroid surgery: quantifying the risk of hematoma, J Otolaryngol Head Neck Surg, 40, 196

Sharma, 2001, Incidence of hematoma associated with ketorolac after TRAM flap breast reconstruction, Plast Reconstr Surg, 107, 352, 10.1097/00006534-200102000-00009

Marin-Bertolin, 1997, A controlled, randomized, double-blind study of ketorolac for postoperative analgesia after plastic surgery, Ann Plast Surg, 38, 478, 10.1097/00000637-199705000-00007

Boers, 2001, NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection, Lancet, 357, 1222, 10.1016/S0140-6736(00)04451-2

Mukherjee, 2001, Risk of cardiovascular events associated with selective COX-2 inhibitors, JAMA, 286, 954, 10.1001/jama.286.8.954

Konstam, 2001, Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib, Circulation, 104, 2280, 10.1161/hc4401.100078

Bresalier, 2005, Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial, N Engl J Med, 352, 1092, 10.1056/NEJMoa050493

White, 2002, Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac, Am J Cardiol, 89, 425, 10.1016/S0002-9149(01)02265-2

White, 2007, Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials, Am J Cardiol, 99, 91, 10.1016/j.amjcard.2006.07.069